Regeneron Pharma (REGN) PT Lowered to $430 at Oppenheimer
Oppenheimer analyst Hartaj Singh lowered ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)